Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of ...
Trailing total returns as of 12/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) ...
Are you having trouble logging in? Follow this step-by-step guide when logging in. You can download this information as a printer friendly version (603 KB) and also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback